Artificial intelligence, particularly machine learning, is transforming genomics by enabling powerful predictions about ...
A new artificial intelligence agent will help staff at the National Institutes of Health generate more detailed information on gene set work by interrogating its own output to help researchers sift ...
Often, the failure of AI pilots isn’t AI itself but whether organizations have the right integration environment.
Mount Sinai and Israel’s largest medical center are using artificial intelligence to map the hidden corners of the human ...
AI in Biotechnology Market worth $22,716.5 million by 2035 with 18.5% CAGR | MarketsandMarkets (TM).
Introduction Intelligent agents constitute task-oriented software that use artificial intelligence (AI) to achieve ...
BC Platforms, a technology company powering global healthcare data and analytics, today launched BC Catalyst, a first-of-its kind AI-native platform that transforms complex genomic and real-world ...
SNS Insider projects the U.S. Artificial Intelligence (AI) in Biotechnology Market to grow from USD 1.14 billion in 2024 to USD 4.24 billion by 2032, at a CAGR of 17.90%.Austin, Nov. 17, 2025 (GLOBE ...
Artificial Intelligence (AI) is transforming the landscape of genomic medicine, unlocking opportunities to accelerate the discovery of relevant alterations, improve and democratise molecular ...